You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 56 No. 6, June 1999 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (5)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Neurogenetics
 •Neuromuscular diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

A Novel Mutation in the Gene for the Adult Skeletal Muscle Sodium Channel {alpha}-Subunit (SCN4A) That Causes Paramyotonia Congenita of von Eulenburg

Ryogen Sasaki, MD; Hiroki Takano, MD, PhD; Keiko Kamakura, MD; Kenichi Kaida, MD; Akira Hirata, MD; Masaaki Saito, MD; Hajime Tanaka, MD; Shigeki Kuzuhara, MD; Shoji Tsuji, MD, PhD

Arch Neurol. 1999;56:692-696.

Background  Paramyotonia congenita (PMC) of von Eulenburg is an autosomal dominant muscular disease characterized by exercise- and cold-induced myotonia and weakness. To date, 18 missense mutations in the adult skeletal muscle sodium channel {alpha}-subunit (SCN4A) gene have been identified to cause a spectrum of muscular diseases, including PMC of von Eulenburg, PMC without cold paralysis, potassium-aggravating myotonia, and hyperkalemic periodic paralysis. However, no obvious correlations can be made between the location or nature of amino acid substitutions in SCN4A and its clinical phenotypes.

Objective  To describe clinical and genetic features of a family with PMC of von Eulenburg.

Results  A Japanese family with cold-induced myotonia and weakness was diagnosed as having PMC of von Eulenburg. This phenotype was identified to be caused by a novel mutation that substituted a glutamic acid residue for a highly conserved glycine residue in the fourth transmembrane segment (S4) of domain IV. This predicted a decrease in positive charge specific for the S4.

Conclusion  In addition to the G1456E identified in this study, 4 mutations that cause a decrease in positive charge in the S4/D4 are associated with the phenotype of PMC of von Eulenburg. This provides an important genotype-phenotype correlation in sodium channelopathies.


From the Department of Neurology, Brain Research Institute, Niigata University, Niigata (Drs Sasaki, Takano, Saito, Tanaka, and Tsuji); Department of Neurology, Mie University School of Medicine, Tsushi (Drs Sasaki and Kuzuhara); and Third Department of Internal Medicine, National Defense Medical College, Tokorozawa (Drs Kamakura, Kaida, and Hirata), Japan.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

RELATED ARTICLE

Archives of Neurology Reader's Choice: Continuing Medical Education
Arch Neurol. 1999;56(6):762-764.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Voltage sensor charge loss accounts for most cases of hypokalemic periodic paralysis
Matthews et al.
Neurology 2009;72:1544-1547.
ABSTRACT | FULL TEXT  

Clinical, electrophysiological, and molecular genetic studies in a new family with paramyotonia congenita
Davies et al.
J. Neurol. Neurosurg. Psychiatry 2000;68:504-507.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.